| __timestamp | Amicus Therapeutics, Inc. | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 9079000 |
| Thursday, January 1, 2015 | 47269000 | 20309000 |
| Friday, January 1, 2016 | 71151000 | 16945000 |
| Sunday, January 1, 2017 | 88671000 | 20559000 |
| Monday, January 1, 2018 | 127200000 | 29641000 |
| Tuesday, January 1, 2019 | 169861000 | 88258000 |
| Wednesday, January 1, 2020 | 156407000 | 162170000 |
| Friday, January 1, 2021 | 192710000 | 167218000 |
| Saturday, January 1, 2022 | 213041000 | 239528000 |
| Sunday, January 1, 2023 | 275270000 | 94252000 |
Infusing magic into the data realm
In the dynamic world of biotechnology, effective cost management is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Amicus Therapeutics, Inc. and Galapagos NV from 2014 to 2023. Over this period, Amicus Therapeutics has seen a staggering 1,230% increase in SG&A expenses, reflecting its aggressive expansion and investment in operational capabilities. In contrast, Galapagos NV experienced a more modest 940% rise, with a notable peak in 2022, where expenses surged by 170% compared to the previous year. This divergence highlights differing strategic approaches: Amicus's rapid scaling versus Galapagos's more measured growth. Understanding these trends offers valuable insights into how these companies navigate the financial challenges of the biotech sector, balancing innovation with fiscal responsibility.
Comparing SG&A Expenses: Gilead Sciences, Inc. vs Galapagos NV Trends and Insights
Intra-Cellular Therapies, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Bio-Techne Corporation vs Galapagos NV: SG&A Expense Trends
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Galapagos NV
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and Amicus Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of MorphoSys AG and Amicus Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Galapagos NV
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? Merus N.V. or Galapagos NV
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights